Tag: therapeutic candidate for COVID-19
SAB Biotherapeutics awarded $57.5 to manufacture its therapeutic candidate for COVID-19
Clinical stage biopharma company SAB Biotherapeutics has been awarded $57.5 million from BARDA and the US Department of Defence for the manufacturing of SAB-185,...
Featured Article
Expressions of interest sought for Wax Converters Textiles
Salea Advisory, on behalf of Administrator Sule Arnautovic, is inviting expressions of interest for the sale or assignment of Wax Converters Textiles Pty Limited, a well-established manufacturing business located in Rutherford, NSW.
